Humana | pharmaphorum

Skip to main content

Wednesday 13 November 2024

twitter linkedin facebook rss

User account menu

Subscribe

Channels

Content type

Categories

Categories

Sort by

Order

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

close

Channels

Content type

Categories

Categories

Sort by

Order

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

Sign up

twitter linkedin facebook rss

Sign in

Humana

News

Tablets on dollar bills (treatment, addiction, aging - concept). Vintage effect.

FTC launches probe into pharmacy benefit management sector

Longstanding claims that one of the reasons for high drug prices in the US is the actions of pharmacy benefit management (PBM) companies – the middlemen in the supply chain – are being form

News

woman-3188744_1280

Humana lawsuit exposes fraud risk in high-growth telehealth ...

Health insurer Humana has filed a lawsuit against telemedicine company QuivvyTech that it says resulted in fraudulent prescriptions worth millions of dollars being written for

Digital

vertex

Digital health round-up: Vertex's machine learning tie-up an...

US pharma hopes to tap into potential of machine learning

News

Boston, Massachusetts, USA skyline.

Humana to open digital health centre in Boston

US health firm Humana is to expand its capability in technology, digital health and analytics with a new centre in Boston, Massachusetts.

Editor's Picks

Alligator pancreatic cancer drug 'nearly doubles' survival

Trump claims comprehensive victory in US election

Novo sheds kidney drug licensed for $1.3bn a year ago

AZ confirms China president has been detained

UK health data ecosystem 'is hampering research'

News

Rachel McMinn, Neurogene's founder and chief executive

Neurogene shares fall on Rett syndrome gene therapy data

Neurogene has reported encouraging efficacy results with its gene therapy for rare genetic disorder Rett syndrome, but investors' concerns about safety seem to be weighing on its share pric

/themes/custom/pharmaphorum_theme/library/img/article-label-image/register.png

Sales & Marketing

pushing two jigsaw pieces together

Enabling site success: Key insights to reducing burden and i...

Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Subscribe

rss facebook linkedin twitter

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2024, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2024, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company